These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7756584)
1. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems. Gustafsson B; Hinkula J Hum Antibodies Hybridomas; 1994; 5(3-4):98-104. PubMed ID: 7756584 [TBL] [Abstract][Full Text] [Related]
2. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. Gustafsson B; Jondal M; Sundqvist VA Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784 [TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells. Garzelli C; Puglisi C; Falcone G Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205 [TBL] [Abstract][Full Text] [Related]
4. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
5. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436 [TBL] [Abstract][Full Text] [Related]
6. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line. Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878 [TBL] [Abstract][Full Text] [Related]
7. Synthetic and natural factors promoting production of murine and human monoclonal antibodies. Astaldi Ricotti GC; Negri C; Cerino A; Bestagno M; Fussi F Ann Ist Super Sanita; 1991; 27(1):155-60. PubMed ID: 1958025 [TBL] [Abstract][Full Text] [Related]
8. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody. Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706 [TBL] [Abstract][Full Text] [Related]
9. Large scale cultivation of an anti-D (IgM) antibody producing human/mouse heterohybridoma. Fizil A; Hencsey Z; Veszely G; Inzelt-Kovács M; Bánkúti L Acta Microbiol Immunol Hung; 1996; 43(4):345-57. PubMed ID: 9147726 [TBL] [Abstract][Full Text] [Related]
10. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. Carlsson R; Mårtensson C; Kalliomäki S; Ohlin M; Borrebaeck CA J Immunol; 1992 Feb; 148(4):1065-71. PubMed ID: 1737926 [TBL] [Abstract][Full Text] [Related]
11. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies. Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S Year Immunol; 1993; 7():213-9. PubMed ID: 8396821 [No Abstract] [Full Text] [Related]
12. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines. Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293 [TBL] [Abstract][Full Text] [Related]
13. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system]. León-González G; Cruz C Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544 [TBL] [Abstract][Full Text] [Related]
14. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865 [TBL] [Abstract][Full Text] [Related]
15. Human monoclonals against erythrocyte antigens. Ernst M; Sonneborn HH Hum Antibodies Hybridomas; 1990; 1(3):122-5. PubMed ID: 1966475 [TBL] [Abstract][Full Text] [Related]
16. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Freund GG; Kulas DT; Way BA; Mooney RA Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537 [TBL] [Abstract][Full Text] [Related]
17. A human hybrid myeloma for production of human monoclonal antibodies. Kozbor D; Tripputi P; Roder JC; Croce CM J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464 [TBL] [Abstract][Full Text] [Related]
18. A human myeloma cell line suitable for the generation of human monoclonal antibodies. Karpas A; Dremucheva A; Czepulkowski BH Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1799-804. PubMed ID: 11172031 [TBL] [Abstract][Full Text] [Related]
19. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C. Gustafsson B; Whitmore E; Tiru M Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271 [TBL] [Abstract][Full Text] [Related]
20. Induction of antibody-producing cell lines by Epstein-Barr virus. Viallat JR; Kourilsky FM Pathol Biol (Paris); 1982 Apr; 30(4):232-42. PubMed ID: 6283460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]